Immune effector cells modulated by secreted soluble factors

The term Immune effector cells modulated by secreted soluble factors describes a broad physiological mechanism rather than a specific molecular entity. It encompasses the regulation of immune cells, such as T lymphocytes, natural killer (NK) cells, and neutrophils, by extracellular proteins including cytokines, chemokines, and growth factors (Abbas et al., Cellular and Molecular Immunology, 2021). These soluble factors act as ligands that bind to specific receptors on the surface of effector cells, triggering intracellular signaling cascades like the JAK-STAT pathway to alter cellular behavior (StatPearls, Physiology, Cytokines, 2023). In disease states like cancer, the balance of these factors is often disrupted, leading to immune evasion or chronic inflammation (Nature Reviews Cancer, 2019). Therapeutic interventions often target this system by administering recombinant cytokines to boost immune activity or using monoclonal antibodies to neutralize inflammatory factors (PubMed, PMC7146047). Because this entry represents a complex biological process involving various cell types and signaling molecules, it is not considered a single therapeutic target in the traditional pharmacological sense.

Other names

Cytokine-modulated immune cellsSoluble factor-responsive effector cellsEffector cell modulationImmune cell signaling by soluble mediators

Modulation of immune cell activity through the binding of secreted ligands (cytokines, chemokines, growth factors) to their respective cognate receptors on effector cells.